This compared to €3.8 million paid to named healthcare professionals in 2016 and a further €3.3 million to healthcare professionals who withheld their name for that year’s data.
The details were compiled by the <strong><em>Medical Independent</em></strong> from 44 separate company pages of the IPHA ToV website, which included seven non-IPHA member participating companies.
The total amount given by pharma to healthcare organisations in 2017 was €8.6 million, compared to just over €10 million in 2016.
In terms of funding for research and development, the participants in the IPHA register spent €15.3 million in 2017.
The IPHA ToV register was launched in 2016, with the first published data relating to 2015. Under data protection law, healthcare professionals can withhold their name from publication.
The consent level from healthcare professionals to disclose their name was 58 per cent for the 2017 data, compared to 57 per cent for 2016 and 55 per cent for 2015, according to the IPHA.
Payments to healthcare professionals are described under the category of ‘contribution to costs of events’, which includes sponsorship, registration fees and travel/accommodation; and the category of ‘fee for service and consultancy’, including fees and related expenses.
The IPHA register is part of a voluntary Europe-wide initiative of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Upon launching the register, the IPHA said it demonstrated “a new level of transparency”.